Short interest in Akari Therapeutics PLC (NASDAQ:AKTX) increased during the last reporting period, rising from 22.55K to 56.94K. This put 0.26% of the company's publicly available shares short.

Short interest for Akari Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Akari Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 133.92K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.